Cetuximab: Fatal tumour lysis syndrome (first report): case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1203, 2008-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib: Fatal tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1292, 2010-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

Dexamethasone: Fatal acute tumour lysis syndrome in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1203, 2008-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Cyclophosphamide/doxorubicin/vincristine: Fatal tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1377, 2011-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Nilotinib: First report of tumour lysis syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1193, 2008-01 ,pp. : 21-22

Adis International

Access to resources Recommend Favorite

Bevacizumab: Tumour lysis syndrome (first report) in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1190, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite